GSH and Ferroptosis: Side-by-Side Partners in the Fight against Tumors

Yulang Jiang1,2,3, Christian Glandorff1,2,3,4, Mingyu Sun1,2,3

  • 1Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.

Insights

Glutathione (GSH) metabolism impacts ferroptosis, a cell death pathway linked to cancer. Modulating GSH offers potential therapeutic strategies for tumor treatment and other diseases.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Glutathione (GSH) is a key antioxidant vital for cellular redox balance.
  • Dysregulated GSH metabolism is linked to various diseases, especially cancer progression.
  • Ferroptosis, a distinct form of cell death, is influenced by cellular redox status.

Purpose of the Study:

  • To investigate the relationship between GSH metabolism and ferroptosis.
  • To explore how altering GSH metabolism affects ferroptosis susceptibility.
  • To identify potential therapeutic targets for cancer and other diseases by modulating GSH.

Main Methods:

  • Comprehensive review of GSH physiological functions, metabolism, and regulation.
  • Analysis of molecular mechanisms linking GSH to ferroptosis.
  • Exploration of therapeutic interventions targeting GSH metabolism.

Main Results:

  • GSH plays a critical role in regulating ferroptosis.
  • Modulation of GSH metabolism can alter cellular sensitivity to ferroptosis.
  • GSH pathway alterations are implicated in tumor development and progression.

Conclusions:

  • Understanding GSH's role in ferroptosis provides insights into disease mechanisms.
  • Targeting GSH metabolism presents a promising therapeutic strategy for ferroptosis-related diseases, including cancer.
  • Further research into GSH regulation could lead to novel treatments for tumors.